Media Inquiries: For all MAVA media inquiries, please contact Audrey Chang at 202-295-8779 or email audrey.chang@harbourgrp.com.
 

 

Check back regularly for news, coverage, and announcements about MAVA.

  

New Enterprise Associates Joins $40M Series A for Alimera Sciences

07/23/2012
Alimera Sciences, a biopharmaceutical company specializing in the research, development and commercialization of prescription ophthalmic pharmaceuticals, has secured a $40 million Series A financing. Palo Alto Investors acted as the lead investor in the offering, with Sofinnova Ventures and New Enterprise Associates also participating.

Read More
« Back